160 related articles for article (PubMed ID: 34397105)
1. Construction of a novel methylation-related prognostic model for colorectal cancer based on microsatellite status.
Cao L; Chen E; Zhang H; Ba Y; Yan B; Li T; Yang J
J Cell Biochem; 2021 Dec; 122(12):1781-1790. PubMed ID: 34397105
[TBL] [Abstract][Full Text] [Related]
2. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
3. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
[TBL] [Abstract][Full Text] [Related]
4. A Novel Prognostic DNA Methylation Panel for Colorectal Cancer.
Chung HH; Kuo CC; Hsiao CW; Chen CY; Hu JM; Hsu CH; Chou YC; Lin YW; Shih YL
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547144
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer.
Arnold CN; Goel A; Compton C; Marcus V; Niedzwiecki D; Dowell JM; Wasserman L; Inoue T; Mayer RJ; Bertagnolli MM; Boland CR
Cancer Biol Ther; 2004 Jan; 3(1):73-8. PubMed ID: 14726676
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
7. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
Cleven AH; Derks S; Draht MX; Smits KM; Melotte V; Van Neste L; Tournier B; Jooste V; Chapusot C; Weijenberg MP; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2014 Jun; 20(12):3261-71. PubMed ID: 24928946
[TBL] [Abstract][Full Text] [Related]
8. Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability.
Ward RL; Cheong K; Ku SL; Meagher A; O'Connor T; Hawkins NJ
J Clin Oncol; 2003 Oct; 21(20):3729-36. PubMed ID: 14551292
[TBL] [Abstract][Full Text] [Related]
9. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
[TBL] [Abstract][Full Text] [Related]
12. The role of hMLH1 methylation in the development of synchronous sporadic colorectal carcinomas.
Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
Dis Colon Rectum; 2002 May; 45(5):674-80. PubMed ID: 12004219
[TBL] [Abstract][Full Text] [Related]
13. A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer.
Xu K; He J; Zhang J; Liu T; Yang F; Ren T
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33034614
[TBL] [Abstract][Full Text] [Related]
14. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer.
Deng GC; Sun DC; Zhou Q; Lv Y; Yan H; Han QL; Dai GH
BMC Genomics; 2021 Nov; 22(1):791. PubMed ID: 34732125
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation in patients with colorectal cancer--correlation with some clinical and morphological features and with local tumour invasion.
Mirchev MB; Kahl P; Friedrichs N; Kotzev IA; Buettner R
Folia Med (Plovdiv); 2010; 52(2):22-30. PubMed ID: 20836393
[TBL] [Abstract][Full Text] [Related]
18. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
19. A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival.
Jia M; Zhang Y; Jansen L; Walter V; Edelmann D; Gündert M; Tagscherer KE; Roth W; Bewerunge-Hudler M; Herpel E; Kloor M; Ulrich A; Burwinkel B; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
Clin Epigenetics; 2019 Jul; 11(1):109. PubMed ID: 31340858
[TBL] [Abstract][Full Text] [Related]
20. The prognostic effect of PTEN expression status in colorectal cancer development and evaluation of factors affecting it: miR-21 and promoter methylation.
Yazdani Y; Farazmandfar T; Azadeh H; Zekavatian Z
J Biomed Sci; 2016 Jan; 23():9. PubMed ID: 26787105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
